On June 29, ALEBUND-B (HKEX: 09637) saw simultaneous share purchases from two of its significant institutional shareholders.

One investor, Global Industry Company, acquired 872,000 shares at an average price of HK$44.0844 per share, with a total investment of approximately HK$38.44 million. This transaction increased its total shareholding to 16.1003 million shares, representing a 7.09% stake in the company.

On the same day, LAV Asset Management (Hong Kong) Limited purchased 450,000 shares at an average price of HK$45.0615 per share, investing approximately HK$20.28 million. This purchase raised LAV's total holdings to about 16.3473 million shares, equating to a 7.20% ownership stake.

Combined, the two institutions purchased over 1.32 million shares, with a cumulative investment nearing HK$58.72 million. This significant capital injection reflects strong institutional confidence in the long-term value prospects of the biopharmaceutical company.